Anteris Technologies Global (NASDAQ:AVR) vs. ReWalk Robotics (NASDAQ:LFWD) Financial Review

Anteris Technologies Global (NASDAQ:AVR) and ReWalk Robotics (NASDAQ:LFWD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

Profitability

This table compares Anteris Technologies Global and ReWalk Robotics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	N/A	N/A	N/A
ReWalk Robotics	-77.21%	-43.02%	-31.53%

Institutional and Insider Ownership

26.8% of ReWalk Robotics shares are held by institutional investors. 2.5% of ReWalk Robotics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Anteris Technologies Global and ReWalk Robotics”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$2.71 million	60.12	N/A	N/A	N/A
ReWalk Robotics	$25.66 million	0.56	-$22.13 million	($3.31)	-0.41

Anteris Technologies Global has higher earnings, but lower revenue than ReWalk Robotics.

Analyst Recommendations

This is a summary of current ratings for Anteris Technologies Global and ReWalk Robotics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	0	0	4	0	3.00
ReWalk Robotics	0	0	3	0	3.00

Anteris Technologies Global presently has a consensus price target of $16.50, indicating a potential upside of 265.04%. ReWalk Robotics has a consensus price target of $9.00, indicating a potential upside of 561.76%. Given ReWalk Robotics’ higher possible upside, analysts clearly believe ReWalk Robotics is more favorable than Anteris Technologies Global.

Summary

Anteris Technologies Global beats ReWalk Robotics on 5 of the 9 factors compared between the two stocks.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.